Senators Criticize Trump Administration’s Demands to Access Health Data as a Condition for Lifesaving Aid

**Senators Raise Concerns Over Trump Administration’s Health Data Demands in Foreign Aid Agreements**

Eight Democratic U.S. senators have criticized the Trump administration’s requirement for foreign countries to share health data as a condition for receiving lifesaving aid. In a letter to Secretary of State Marco Rubio, the lawmakers called the demands “unprecedented” and inconsistent with U.S. policies protecting American citizens’ data privacy.

The senators, led by Senate Minority Leader Chuck Schumer and Georgia Senator Raphael Warnock, referenced a June report by ProPublica detailing agreements between the U.S. and African nations. Experts warned that the deals lack standard safeguards found in most data-sharing agreements, increasing the risk of exposure, misuse, or commercialization of personal health information without consent.

The letter, sent last week, requests a briefing on the agreements’ data requirements and written responses to a series of questions by the end of August. Other signatories include Senators Tim Kaine, Chris Van Hollen, Brian Schatz, Amy Klobuchar, Christopher Coons, and Jeff Merkley.

The senators expressed concern that the demands could set a harmful international precedent, potentially undermining U.S. privacy protections. They noted that the requirements appear to conflict with the Trump administration’s National Cyber Strategy, which emphasizes privacy rights for Americans.

The letter highlights a data-sharing agreement between the U.S. and Uganda, first reported by ProPublica, which grants American officials and contractors direct access to Uganda’s health data systems. The senators wrote that while global health programs have historically included data-sharing components, they have never before required such unfettered access to foreign electronic health records.

The lawmakers posed more than a dozen questions to Rubio, including why the agreements have not been made public as federal law requires. They also asked whether the data would be shared with U.S.-based third parties for commercial purposes, such as training artificial intelligence models. Additional concerns included the privacy rights of foreign citizens whose data is transferred to the U.S. and how those rights would be enforced in cases of data breaches or misuse.

The agreements come as the State Department has taken on greater responsibility for foreign aid distribution following the Trump administration’s restructuring of the U.S. Agency for International Development and reductions in funding for international health programs at the Centers for Disease Control and Prevention. Congress mandated continued foreign aid, forcing the State Department to develop new mechanisms for distributing funds and monitoring their use.

Previously, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) maintained separate systems for handling anonymized data. The new agreements, however, provide direct access to foreign governments’ health data systems. The U.S. has also secured agreements for countries to share pathogen specimens and related information.

The effort to establish these new aid arrangements was led by Brad Smith, a former healthcare entrepreneur who oversaw significant budget cuts at the Department of Health and Human Services before joining the State Department. The Uganda agreement provides up to $1.7 billion in aid for HIV, tuberculosis, and malaria, among other diseases, but requires extensive data sharing.

The administration’s approach is part of the America First Global Health Strategy, which aims to promote U.S. prosperity and health innovations. Rubio previously stated that aid would be distributed in ways that directly benefit the American people and national interests.

Privacy experts warn that mishandling health data under these agreements could have severe consequences. Disclosure of sensitive health information, such as abortion history, mental health conditions, or sexually transmitted diseases, could lead to discrimination and violence, particularly in regions where such information carries significant stigma.

The agreements reviewed by ProPublica do not guarantee that affected individuals will have control over how their data is used or whether they would receive any financial benefits from its commercialization.

The State Department declined to address specific questions about the senators’ letter, stating it does not comment on congressional correspondence. In a statement to ProPublica, a spokesperson defended the data-sharing requirements, asserting that no personally identifiable information is collected or reviewed. The spokesperson said the agreements involve only aggregated, de-identified data, consistent with longstanding practices in global health programs and compliant with each country’s laws. The statement also denied that any country was coerced into signing the agreements.